Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health

Generated: September 18, 2019

DrugPatentWatch Database Preview

Patent: 9,592,303

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,592,303
Title:Enzyme-catalyzed synthesis of site-specific and stoichiometric biomolecule-polymer conjugates
Abstract: Methods for producing polypeptide-polymer conjugates include attachment of an initiator agent to a polypeptide specifically at the C-terminus of the polypeptide using a sortase enzyme and in situ polymerization of a polymer from the C-terminus. The polypeptide-polymer conjugates may have desirable pharmacological properties and may be used therapeutically.
Inventor(s): Chilkoti; Ashutosh (Durham, NC), Qi; Yizhi (Durham, NC)
Assignee: Duke University (Durham, NC)
Application Number:14/894,731
Patent Claims:see list of patent claims

Details for Patent 9,592,303

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Try a Free Trial Duke University (Durham, NC) 2033-05-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,592,303

Country Patent Number Publication Date
China 109152818 Jan 04, 2019
European Patent Office 3003342 Apr 13, 2016
European Patent Office 3003342 Mar 08, 2017
European Patent Office 3393500 Oct 31, 2018
United States of America 2016122451 May 05, 2016
United States of America 2017233714 Aug 17, 2017
United States of America 2017239363 Aug 24, 2017
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.